• May 23, 2025Bachem scales up peptide, oligonucleotide production | Northway inks manufacturing pact with Kaida BioPharma
    May 22, 2025Thermo Fisher to be Mirai Bio’s preferred CDMO | CellProthera selects CELLforCURE for Phase 3 GMP manufacturing
    May 21, 2025Cellino nabs FDA AMT nod for iPSC manufacturing | GC Biopharma and Körber fast‑track MES rollout
    May 20, 2025Biosimilar approvals seen as boon for CMOs | Trump launches AI drug manufacturing push
    May 17, 2025World’s first mRNA-based personalized CRISPR therapy | Thermo Fisher provides manufacturing for Phase 3 program
    May 16, 2025Roche warns Trump’s pricing order threatens $50B US investment | Sanofi commits $20B to US R&D, manufacturing
    May 15, 2025WuXi Biologics sells German site to Terumo for $168M | Recipharm, PLG team up on drug development and approvals
    May 14, 2025Bayer says tariffs won’t impact manufacturing footprint | Piramal Pharma to expand two US sites with $90M investment
    May 13, 2025Genentech plans $700M NC plant | Lilly invests $250M in Purdue partnership
    May 10, 2025Takeda plans $30B US investment over 5 years | Lonza reaffirms 2025 outlook after strong Q1
    May 9, 2025Gilead invests $11B to expand US manufacturing | Ratio Therapeutics plans new radiopharma site in Utah
    May 8, 2025AGC teams with Novelty Nobility on antibody drug | Aptar CSP opens cGMP packaging site
    May 7, 2025US exercises $144M option for freeze-dried mpox vaccine | Xellia to close Copenhagen site over 10 years
    May 6, 2025Samsung Biologics inks $518M deal with unnamed US firm | Matica Bio, NCTM team up on CGT development
    May 3, 2025Lilly CEO urges tax reform over tariffs | BMS shuts Illinois viral vector site
    May 2, 2025Biogen says 2025 outlook unaffected by potential tariffs | EMA approves new API site for Pegasys
    May 1, 2025Tariff uncertainty deters Pfizer US investment | AstraZeneca weighs manufacturing shift to US
    Apr 30, 2025 Merck begins $1B Delaware Keytruda site | Novartis touts $23B US manufacturing investment
    Apr 29, 2025AbbVie to invest $10B in US manufacturing | Amgen’s $900M expansion in Ohio
    Apr 26, 2025BMS, Merck, Roche plan for tariffs | PCI buys Ajinomoto Althea | FDA clears Ferring site
    Apr 25, 2025Thermo invests $2B in US, hit by tariffs | Catalent, Silexion team on siRNA | Lotte opens ADC facility
    Apr 24, 2025Samsung Biologics doubles profit, launches new plant | Danaher expects $350M tariff hit, plans to offset
    Apr 23, 2025Roche commits $50B to US R&D, manufacturing | Regeneron, Fujifilm ink $3B production deal
    Apr 22, 2025Lilly to make weight-loss pill in US | WuXi Biologics touts PPQ campaign for 15,000L production line
    Apr 19, 2025Moderna’s UK site licensed by MHRA for mRNA production | Ritedose adds 7th Syntegon line to boost vial packaging
    Latest Edition